| iCAD is a medical technology company providing cancer detection and therapy solutions. Co.'s segments are: Cancer Detection, which includes image analysis and workflow solutions that enable healthcare personnel to identify pathologies and pinpoint prevalent cancers earlier, and various Artificial Intelligence and Computer-Aided Detection systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography; and Cancer Therapy, which provides the Xoft Axxent Electronic Brachytherapy System, an isotope-free cancer treatment platform technology for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer. We show 41 historical shares outstanding datapoints in our ICAD shares outstanding history coverage, used to compute ICAD market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ICAD market cap history over the course of time is important for investors
interested in comparing ICAD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ICAD versus a peer is one thing; comparing
ICAD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ICAD can fluctuate over the course of history.
With this page we aim to empower investors researching ICAD by allowing them to research the ICAD market cap history.